The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Agoraphobia

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Agoraphobia

 

Psychiatry related information on Agoraphobia

 

High impact information on Agoraphobia

 

Chemical compound and disease context of Agoraphobia

 

Biological context of Agoraphobia

 

Gene context of Agoraphobia

 

Analytical, diagnostic and therapeutic context of Agoraphobia

References

  1. Panic disorder as a chronic illness. Liebowitz, M.R. The Journal of clinical psychiatry. (1997) [Pubmed]
  2. Panic disorder with agoraphobia following tuberculous meningitis. Chand, S.P., Chand, P. Singapore medical journal. (1996) [Pubmed]
  3. Panic disorder and agoraphobia: fear of fear or fear of the symptoms produced by hyperventilation? Ley, R. Journal of behavior therapy and experimental psychiatry. (1987) [Pubmed]
  4. Parental concordance and comorbidity for psychiatric disorder and associate risks for current psychiatric symptoms and disorders in a community sample of juvenile twins. Foley, D.L., Pickles, A., Simonoff, E., Maes, H.H., Silberg, J.L., Hewitt, J.K., Eaves, L.J. Journal of child psychology and psychiatry, and allied disciplines. (2001) [Pubmed]
  5. Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Woods, S.W., Charney, D.S., Loke, J., Goodman, W.K., Redmond, D.E., Heninger, G.R. Arch. Gen. Psychiatry (1986) [Pubmed]
  6. Three cases of overlap between panic disorder, social phobia, and agoraphobia. Goldstein, S. The Journal of clinical psychiatry. (1987) [Pubmed]
  7. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. Bakker, A., van Dyck, R., Spinhoven, P., van Balkom, A.J. The Journal of clinical psychiatry. (1999) [Pubmed]
  8. Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Rothe, C., Gutknecht, L., Freitag, C., Tauber, R., Mössner, R., Franke, P., Fritze, J., Wagner, G., Peikert, G., Wenda, B., Sand, P., Jacob, C., Rietschel, M., Nöthen, M.M., Garritsen, H., Fimmers, R., Deckert, J., Lesch, K.P. Int. J. Neuropsychopharmacol. (2004) [Pubmed]
  9. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. Shear, M.K., Rucci, P., Williams, J., Frank, E., Grochocinski, V., Vander Bilt, J., Houck, P., Wang, T. Journal of psychiatric research. (2001) [Pubmed]
  10. The cross-national epidemiology of panic disorder. Weissman, M.M., Bland, R.C., Canino, G.J., Faravelli, C., Greenwald, S., Hwu, H.G., Joyce, P.R., Karam, E.G., Lee, C.K., Lellouch, J., Lépine, J.P., Newman, S.C., Oakley-Browne, M.A., Rubio-Stipec, M., Wells, J.E., Wickramaratne, P.J., Wittchen, H.U., Yeh, E.K. Arch. Gen. Psychiatry (1997) [Pubmed]
  11. Cortisol and sodium lactate-induced panic. Hollander, E., Liebowitz, M.R., Gorman, J.M., Cohen, B., Fyer, A., Klein, D.F. Arch. Gen. Psychiatry (1989) [Pubmed]
  12. Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment. Charney, D.S., Heninger, G.R. Arch. Gen. Psychiatry (1986) [Pubmed]
  13. Diazepam and propranolol in panic disorder and agoraphobia. Noyes, R., Anderson, D.J., Clancy, J., Crowe, R.R., Slymen, D.J., Ghoneim, M.M., Hinrichs, J.V. Arch. Gen. Psychiatry (1984) [Pubmed]
  14. Pramipexole augmentation in panic with agoraphobia. Marazziti, D., Presta, S., Pfanner, C., Dell'Osso, L., Cassano, G.B. The American journal of psychiatry. (2001) [Pubmed]
  15. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Ballenger, J.C., Wheadon, D.E., Steiner, M., Bushnell, W., Gergel, I.P. The American journal of psychiatry. (1998) [Pubmed]
  16. Plasma serotonin levels in agoraphobia. Evans, L., Schneider, P., Ross-Lee, L., Wiltshire, B., Eadie, M., Kenardy, J., Hoey, H. The American journal of psychiatry. (1985) [Pubmed]
  17. Salivary cortisol in panic attacks. Bandelow, B., Wedekind, D., Pauls, J., Broocks, A., Hajak, G., Rüther, E. The American journal of psychiatry. (2000) [Pubmed]
  18. Sertraline in the treatment of panic disorder: a double-blind multicenter trial. Pohl, R.B., Wolkow, R.M., Clary, C.M. The American journal of psychiatry. (1998) [Pubmed]
  19. Dexamethasone suppression test in agoraphobia. Schneider, P., Whiteford, H., Hoey, H., Kenardy, J., Wiltshire, B., Evans, L. The American journal of psychiatry. (1983) [Pubmed]
  20. Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Hamilton, S.P., Slager, S.L., De Leon, A.B., Heiman, G.A., Klein, D.F., Hodge, S.E., Weissman, M.M., Fyer, A.J., Knowles, J.A. Neuropsychopharmacology (2004) [Pubmed]
  21. Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice. Allsopp, L.F., Cooper, G.L., Poole, P.H. Current medical research and opinion. (1984) [Pubmed]
  22. Carbon dioxide/oxygen challenge test in panic disorder. Perna, G., Battaglia, M., Garberi, A., Arancio, C., Bertani, A., Bellodi, L. Psychiatry research. (1994) [Pubmed]
  23. Cytokine production in panic disorder patients. Weizman, R., Laor, N., Wiener, Z., Wolmer, L., Bessler, H. Clinical neuropharmacology. (1999) [Pubmed]
  24. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Wilens, T.E., Kwon, A., Tanguay, S., Chase, R., Moore, H., Faraone, S.V., Biederman, J. The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions. (2005) [Pubmed]
  25. Depression, agoraphobia, and the DST. Stewart, J.T., Lawlor, B.A. The Journal of clinical psychiatry. (1985) [Pubmed]
  26. Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder. Broocks, A., Bandelow, B., Koch, K., Bartmann, U., Kinkelbur, J., Schweiger, U., Hohagen, F., Hajak, G. Neuropsychopharmacology (2002) [Pubmed]
  27. Utilization of behavioral methods in a multicenter anxiety disorders study. Goisman, R.M., Rogers, M.P., Steketee, G.S., Warshaw, M.G., Cuneo, P., Keller, M.B. The Journal of clinical psychiatry. (1993) [Pubmed]
  28. A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia. Cottraux, J., Note, I.D., Cungi, C., Légeron, P., Heim, F., Chneiweiss, L., Bernard, G., Bouvard, M. The British journal of psychiatry : the journal of mental science. (1995) [Pubmed]
  29. Experiential cognitive therapy in the treatment of panic disorders with agoraphobia: a controlled study. Vincelli, F., Anolli, L., Bouchard, S., Wiederhold, B.K., Zurloni, V., Riva, G. Cyberpsychology & behavior : the impact of the Internet, multimedia and virtual reality on behavior and society. (2003) [Pubmed]
 
WikiGenes - Universities